Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
RYTM
Stock Latest News
The Fly
Rhythm Pharmaceuticals price target raised to $77 from $72 at Morgan Stanley
3h ago
RYTM
Premium
Ratings
Promising Phase 3 Results for Setmelanotide in Hypothalamic Obesity Drive Buy Rating
4h ago
RYTM
Premium
The Fly
BofA upgrades Rhythm Pharmaceuticals to Buy on ‘likely approvable’ data
6h ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $91 from $80 at Wells Fargo
6h ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals upgraded to Buy from Neutral at BofA
6h ago
RYTM
Premium
Ratings
Promising Phase 3 Results for Setmelanotide Boost Rhythm Pharmaceuticals’ Market Potential
10h ago
RYTM
Premium
Company Announcements
Rhythm Pharmaceuticals Announces Positive Phase 3 Trial Results
10h ago
8K
RYTM
Premium
The Fly
Rhythm Pharmaceuticals says Phase 3 TRANSCEND trial meets primary endpoint
11h ago
RYTM
Premium
The Fly
Roku, Tesla among Q2 Tactical Ideas at Wells Fargo
6d ago
COF
KKR
Premium
Ratings
Strategic Positioning and Promising Trials Drive Buy Rating for Rhythm Pharmaceuticals
7d ago
RYTM
Premium
Ratings
Promising Potential of Rhythm Pharmaceuticals’ Setmelanotide in Treating Hypothalamic Obesity
7d ago
RYTM
Premium
Ratings
Buy Rating for Rhythm Pharmaceuticals: Strategic Moves in Asia and Promising Setmelanotide Trials Drive Positive Outlook
14d ago
RYTM
Premium
Ratings
Strategic Advancements and Market Opportunities Drive Buy Rating for Rhythm Pharmaceuticals
15d ago
RYTM
Premium
Company Announcements
Rhythm Pharmaceuticals Reacquires Setmelanotide Rights in Asia
18d ago
8K
RYTM
Premium
The Fly
Rhythm Pharmaceuticals reacquires rights to Imcivree in China for $6.3M
18d ago
RYTM
Premium
Market News
3 Best Stocks to Buy Now, 3/20/2025, According to Top Analysts
18d ago
CZR
GEV
Premium
The Fly
Rhythm Pharmaceuticals gets orphan drug designation for setmelanotide in Japan
19d ago
RYTM
Premium
Ratings
Buy Rating for Rhythm Pharmaceuticals: Setmelanotide’s Potential in Addressing Unmet Needs in Hypothalamic Obesity
19d ago
RYTM
Premium
Ratings
Rhythm Pharmaceuticals: Buy Rating on Promising Setmelanotide Phase 3 Data for Hypothalamic Obesity
19d ago
RYTM
Premium
The Fly
Citizens JMP pharmaceuticals analysts hold analyst/industry conference call
20d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $66 from $64 at Needham
20d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals, Raymond A. Wood Fountain announce research collab
20d ago
RYTM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
